Literature DB >> 21748408

Combined methylmalonic acidemia and homocystinuria, cblC type. II. Complications, pathophysiology, and outcomes.

Nuria Carrillo-Carrasco1, Charles P Venditti.   

Abstract

Combined methylmalonic acidemia and homocystinuria, cblC type, is stated to be the most common inborn error of intracellular cobalamin metabolism. The disorder can display a wide spectrum of clinical manifestations, spanning the prenatal period through late adulthood. While increased homocysteine concentrations and impaired methyl group metabolism may contribute to disease-related complications, the characteristic macular and retinal degeneration seen in many affected patients appears to be unique to cblC disease. The early detection of cblC disease by newborn screening mandates a careful assessment of therapeutic approaches and provides a new opportunity to improve the outcome of affected patients. The following article reviews the current knowledge on the complications, pathophysiology, and outcome of cblC disease in an effort to better guide clinical practice and future therapeutic trials.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21748408      PMCID: PMC3529128          DOI: 10.1007/s10545-011-9365-x

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  114 in total

1.  Optic neuropathy in methylmalonic acidemia: the role of neuroprotection.

Authors:  Sergio Pinar-Sueiro; Ricardo Martínez-Fernández; Sergio Lage-Medina; Luis Aldamiz-Echevarria; Elena Vecino
Journal:  J Inherit Metab Dis       Date:  2010-05-07       Impact factor: 4.982

2.  Pathogenesis of subacute combined degeneration: a result of methyl group deficiency.

Authors:  J M Scott; J J Dinn; P Wilson; D G Weir
Journal:  Lancet       Date:  1981-08-15       Impact factor: 79.321

3.  Hereditary defect of cobalamin metabolism (homocystinuria and methylmalonic aciduria) of juvenile onset.

Authors:  R Gold; U Bogdahn; L Kappos; K V Toyka; E R Baumgartner; B Fowler; U Wendel
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-01       Impact factor: 10.154

4.  Disturbed visual system function in methionine synthase deficiency.

Authors:  Charlotte M Poloschek; Brian Fowler; Renate Unsold; Birgit Lorenz
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2004-11-18       Impact factor: 3.117

5.  Optic atrophy in association with cobalamin C (cblC) disease.

Authors:  N Patton; S Beatty; I C Lloyd; J E Wraith
Journal:  Ophthalmic Genet       Date:  2000-09       Impact factor: 1.803

Review 6.  Cobalamin C defect: natural history, pathophysiology, and treatment.

Authors:  Diego Martinelli; Federica Deodato; Carlo Dionisi-Vici
Journal:  J Inherit Metab Dis       Date:  2010-07-15       Impact factor: 4.982

7.  Treatment responsive executive and behavioral dysfunction associated with Vitamin B12 deficiency.

Authors:  Gülden Akdal; Görsev G Yener; Pinar Kurt
Journal:  Neurocase       Date:  2008       Impact factor: 0.881

8.  Modification of fibrinogen by homocysteine thiolactone increases resistance to fibrinolysis: a potential mechanism of the thrombotic tendency in hyperhomocysteinemia.

Authors:  Derrick L Sauls; Evelyn Lockhart; Maria Esteban Warren; Angela Lenkowski; Susan E Wilhelm; Maureane Hoffman
Journal:  Biochemistry       Date:  2006-02-28       Impact factor: 3.162

9.  Clinical heterogeneity in cobalamin C variant of combined homocystinuria and methylmalonic aciduria.

Authors:  G A Mitchell; D Watkins; S B Melançon; D S Rosenblatt; G Geoffroy; J Orquin; M B Homsy; L Dallaire
Journal:  J Pediatr       Date:  1986-03       Impact factor: 4.406

10.  The adolescent and adult form of cobalamin C disease: clinical and molecular spectrum.

Authors:  C Thauvin-Robinet; E Roze; G Couvreur; M-H Horellou; F Sedel; D Grabli; G Bruneteau; C Tonneti; A Masurel-Paulet; D Perennou; T Moreau; M Giroud; H Ogier de Baulny; S Giraudier; L Faivre
Journal:  J Neurol Neurosurg Psychiatry       Date:  2008-02-01       Impact factor: 10.154

View more
  37 in total

1.  Cobalamin C deficiency in an adolescent with altered mental status and anorexia.

Authors:  Maria H Rahmandar; Amanda Bawcom; Mary E Romano; Rizwan Hamid
Journal:  Pediatrics       Date:  2014-11-03       Impact factor: 7.124

2.  Response to: 'Methylcobalamine is effective in peripheral neuropathies'.

Authors:  K Thakkar; G Billa
Journal:  Eur J Clin Nutr       Date:  2015-01-21       Impact factor: 4.016

Review 3.  Renal dysfunction in methylmalonic acidurias: review for the pediatric nephrologist.

Authors:  Marina A Morath; Friederike Hörster; Sven W Sauer
Journal:  Pediatr Nephrol       Date:  2012-07-20       Impact factor: 3.714

4.  An X-linked cobalamin disorder caused by mutations in transcriptional coregulator HCFC1.

Authors:  Hung-Chun Yu; Jennifer L Sloan; Gunter Scharer; Alison Brebner; Anita M Quintana; Nathan P Achilly; Irini Manoli; Curtis R Coughlin; Elizabeth A Geiger; Una Schneck; David Watkins; Terttu Suormala; Johan L K Van Hove; Brian Fowler; Matthias R Baumgartner; David S Rosenblatt; Charles P Venditti; Tamim H Shaikh
Journal:  Am J Hum Genet       Date:  2013-09-05       Impact factor: 11.025

5.  Increased ER stress as a mechanism of retinal neurovasculopathy in mice with severe hyperhomocysteinemia.

Authors:  Amany Tawfik; Sylvia B Smith
Journal:  Austin J Clin Ophthalmol       Date:  2014-06-16

6.  Thrombotic microangiopathy and breastfeeding: where is the link? Answers.

Authors:  Jean Daniel Delbet; Tim Ulinski
Journal:  Pediatr Nephrol       Date:  2017-08-15       Impact factor: 3.714

7.  Milder clinical and biochemical phenotypes associated with the c.482G>A (p.Arg161Gln) pathogenic variant in cobalamin C disease: Implications for management and screening.

Authors:  Mohammed Almannai; Ronit Marom; Kristian Divin; Fernando Scaglia; V Reid Sutton; William J Craigen; Brendan Lee; Lindsay C Burrage; Brett H Graham
Journal:  Mol Genet Metab       Date:  2017-06-29       Impact factor: 4.797

8.  A Primary Study on Down-Regulated miR-9-1 and Its Biological Significances in Methylmalonic Acidemia.

Authors:  Yanfei Li; Tao Peng; Xiaohan Wang; Ranran Duan; Huili Gao; Wenjuan Guan; Junfang Teng; Yanjie Jia
Journal:  J Mol Neurosci       Date:  2014-01-04       Impact factor: 3.444

9.  A high frequency and geographical distribution of MMACHC R132* mutation in children with cobalamin C defect.

Authors:  Rajdeep Kaur; Savita Verma Attri; Arushi Gahlot Saini; Naveen Sankhyan
Journal:  Amino Acids       Date:  2021-01-30       Impact factor: 3.520

10.  Clinical characteristics of hemolytic uremic syndrome secondary to cobalamin C disorder in Chinese children.

Authors:  Qi-Liang Li; Wen-Qi Song; Xiao-Xia Peng; Xiao-Rong Liu; Le-Jian He; Li-Bing Fu
Journal:  World J Pediatr       Date:  2015-08-08       Impact factor: 2.764

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.